Stock Analysis
Cann Group Full Year 2023 Earnings: AU$0.091 loss per share (vs AU$0.079 loss in FY 2022)
Cann Group (ASX:CAN) Full Year 2023 Results
Key Financial Results
- Revenue: AU$21.7m (up 93% from FY 2022).
- Net loss: AU$33.8m (loss widened by 28% from FY 2022).
- AU$0.091 loss per share (further deteriorated from AU$0.079 loss in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Cann Group's share price is broadly unchanged from a week ago.
Risk Analysis
You still need to take note of risks, for example - Cann Group has 5 warning signs (and 2 which are concerning) we think you should know about.
Valuation is complex, but we're helping make it simple.
Find out whether Cann Group is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About ASX:CAN
Cann Group
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, supplying, and selling medicinal cannabis.
Slightly overvalued with worrying balance sheet.